Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

22 year old Merline receives treatment at a Medecins Sans Frontiers (MSF) clinic at a displaced persons camp in Fateb, Bangui, 2015 Photograph by Luca Sola
Press release
Press release |
12 May 2015
Intellectual property and trade

MSF responds to publication of new edition of WHO Model List of Essential Medicines 

1 min
Joanne Liu (International President), Ronald Kremer (OCA Health Advisor) and Brice dele Vigne visited the ebola treatment centre in Kailahun, Sierra Leone on August 2011 Photograph by P.K. Lee
Press release
Press release |
11 May 2015
Research and development

MSF and DNDi Join Call for a Biomedical Research and Development Fund and Mechanism to Meet Pressing Global Health Needs

4 min
Press release |
05 May 2015
Hepatitis C

Gilead: Stop Blocking Access to Hepatitis C Treatment

4 min
An Extensively Drug Resistant Tuberculosis (XDR-TB) patient undergoing an audiometry test to assess the hearing ability, as hearing loss is one of the side-effects of DRTB drugs Photograph by Anshul Uniyal
Press release
Press release |
29 April 2015
Tuberculosis

MSF response to announcement of Otsuka’s donation programme for the TB drug delamanid

3 min
Campaign asking Pfizer & GSK to drop the prices of pneumonia vaccines down to 5$/child Photograph by MSF

When prices are hidden, you can essentially set the price as high as you'd like. No one would know, right? It's absurd, but unfortunately, this is the way pharmaceutical companies set prices for their life-saving pneumonia vaccines.

Press release
Press release |
23 April 2015
Vaccines

MSF kicks off global ████ to reduce the price of ████ to $5 in developing countries

5 min
Press release |
13 April 2015
Intellectual property and trade
GermanyIndia

MSF response to Indian Prime Minister’s visit to Germany and EU India FTA negotiations

A man holds antiretroviral drugs at an activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015 Photograph by Stefan Heunis
Press release
Press release |
31 March 2015
Tuberculosis
LatviaEuropean Union

As first EU Ministerial meeting on tuberculosis closes, MSF calls on the EU to triple funding for TB R&D

3 min
MSF staff conducts a medical consultation with a female MDR-TB patient at MSF’s Insein Prison clinic, Yangon, Myanmar. Photograph by Aye Pyae Sone
Press release
Press release |
24 March 2015
Tuberculosis
European Union

MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury